Home Clinical Topics FDA approves new osteoporosis treatment

FDA approves new osteoporosis treatment

Author(s):

On April 9, the FDA approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of fracture.

Read more at FDA.gov.

LEAVE A REPLY

Please enter your comment!
Please enter your name here